JR

Janak Rani Monga

Active Director Director DIN 01686622
DIN 01686622 First appointment Dec 2002 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2002
Shareholding value β€’β€’β€’β€’ Premium profile

About Janak Rani Monga

Data last updated:

Janak Rani Monga is a Director at Kumar Drug Pharmaceuticals Pvt Ltd (since 2002). The company operates in Chemicals.

DIN 01686622
Primary Designation Director
Industry Chemicals
First Appointment 12 Dec 2002
Oldest Company Age 34 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kumar Drug Pharmaceuticals Pvt Ltd U24232PB1992PTC012395
Director12 Dec 20021992Active

Board colleagues of Janak Rani Monga

NameDINCompanyDesignation
Rajesh Monga01686595Kumar Drug Pharmaceuticals Pvt LtdManaging Director
Shailja Monga01686613Kumar Drug Pharmaceuticals Pvt LtdDirector

Directorship timeline

Open interactive timeline →
Kumar Drug Pharmaceuticals Pvt Ltd
Premium access

Shareholding and investment profile for Janak Rani Monga

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Janak Rani Monga

Janak Rani Monga currently holds 1 directorship: Kumar Drug Pharmaceuticals Pvt Ltd (Director, since 12 Dec 2002).

Janak Rani Monga was first appointed on 12 Dec 2002 as Director at Kumar Drug Pharmaceuticals Pvt Ltd.

The current boards of Janak Rani Monga's companies include Rajesh Monga (Kumar Drug Pharmaceuticals Pvt Ltd), Shailja Monga (Kumar Drug Pharmaceuticals Pvt Ltd).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available